Q-Fever: A global health risk

The decision to stop production of the vaccine for Q-Fever will leave Australia and the international community vulnerable to the health risks of Q-Fever infection, according to one of the country's leading researchers.

The only manufacturer of the vaccine, CSL Ltd, formerly known as the Commonwealth Serum Laboratories, has announced it will stop its production from March 2007.

"Q-Fever is on the short-list for organisms thought to be potential threats for bioterrorism," said Professor Andrew Lloyd, from the Inflammatory Diseases Research Unit at the University of New South Wales (UNSW). "Loss of the vaccine, Q-Vax, would be a serious drawback for public safety.

"Without it, we will be leaving ourselves open to outbreaks of the disease which immobilise and cause great suffering to large numbers of people, particularly in country areas. In some instances, complications from the disease may be life threatening.

"My research has shown that the incidence of Q-Fever is closely related to drought conditions. The organism involved is resistant to environmental extremes and blows around in the dust. People who work with animals are particularly vulnerable, but the animals themselves show no sign of the disease."

Professor Lloyd said any outbreak of the disease, which is highly infectious and for which there is no alternative prevention strategy, could also have serious economic ramifications. These include direct health care costs and lost productivity in the major rural industries of beef, lamb and wool production, amongst others.

"Before the widespread uptake of the vaccine, there were approximately 100 WorkCover claims made annually in NSW alone. A single settlement of over a million dollars was made in the NSW Supreme Court in 1997 to a meat inspector suffering prolonged illness after Q-Fever," said Professor Lloyd.

Professor Lloyd said approximately one in three individuals living in rural areas will be inf

Contact: Susi Hamilton
Research Australia

Page: 1 2

Related biology news :

1. Revolutionary global environment fund announces $50M expansion
2. 1,000-year-old Arctic ponds disappearing due to global warming
3. Desertification: UN experts prescribe global policy overhaul to avoid looming mass migrations
4. Scientists call for global push to advance research in synthetic biology
5. Northern forests less effective than tropical forests in reducing global warming
6. UN issues analysis of global investors sustainable energy gold rush
7. Gannet population under threat from global warming
8. Yale journal examines the global impact of cities
9. Researchers examine carbon capture and storage to combat global warming
10. QUT microgravity tower attracts global scientific community
11. Study warns climate change and deforestation will lead to declines in global bird diversity

Post Your Comments:

(Date:8/19/2019)... ... August 19, 2019 , ... Since ... use of ultra-thin two dimensional slices which are placed on microscope slides, stained ... complex tissues and complicated features such as vasculature and thus researchers in the ...
(Date:8/15/2019)... ... ... Deep Science Ventures (DSV), a new paradigm for applied science, today announced ... 100 companies over the next 10 years to address the urgent need for new ... was founded to create a better method for launching science companies; one that takes ...
(Date:8/15/2019)... ... , ... Serialization deadlines in the US and European Union ... becomes fully applied in the United States in 2023, pharmaceutical companies are scrutinizing ... most regulations?including the Drug Supply Chain Security Act (DSCSA)?have required minimal system capabilities. ...
Breaking Biology News(10 mins):
(Date:8/15/2019)... ... August 15, 2019 , ... PathSensors announced today that Roger ... of the Institute of Food Technologists (IFT) Board of Directors, Illinois Institute of ... for Food Safety and Applied Nutrition (JIFSAN) Advisory Council and the University of ...
(Date:8/14/2019)... STATE COLLEGE, Pa. (PRWEB) , ... August 13, ... ... leader in nuclear receptor and in vitro toxicology testing solutions, announced the appointment ... of healthcare industry experience to the Board. , Mark McLoughlin will lend his ...
(Date:8/14/2019)... ... August 13, 2019 , ... ... prepackaged mobile phases for QC laboratories. After gaining a few significant clients, Lifecycle ... approach into a valued supplier of manufacturing processing solutions, including reagents for tissue ...
(Date:8/8/2019)... , ... August 08, 2019 , ... ... Agents for sales and service organizations, today announced that the company’s Studio ... Award for the IVA market . Inference will officially accept the award at ...
Breaking Biology Technology:
Cached News: